1/26/2015
The Obama administration unveiled an ambitious plan to control health costs by moving the $2.9 trillion U.S. health systems away from costly fee-for-service medicine, beginning with the Medicare program for the elderly and disabled. | Read More
1/26/2015
According to a report from Avalere Health, consumers purchasing health insurance on the exchange are having a tough time determining out-of-pocket costs for specialty medications due to new benefit designs and a lack of clear information provided. | Read More
1/26/2015
A new wave of experimental cancer drugs that directly recruit the immune system's powerful T cells are proving to be immensely effective weapons against tumors, potentially transforming the $100 billion global market for drugs that fight the disease. | Read More

WEEKLY TOP ARTICLES

1/26/2015

The FDA approved Teva Pharmaceutical Industries Ltd's generic version of AstraZeneca Plc's Nexium to treat acid reflux.

continue reading
1/26/2015

The FDA approved NPS Pharmaceuticals Inc's drug Natpara to control hypocalcemia in patients with hypoparathyroidism.

continue reading
1/26/2015

Women with breast cancer often don't know what kind of tumors they have, a new study found.

continue reading
1/26/2015

The FDA approved Rockwell Medical Inc's drug Triferic for treating iron loss in chronic kidney disease patients on dialysis.

continue reading
1/23/2015

The risk of developing drug resistance to pre-exposure prophylaxis (PrEP) for HIV may be low compared to the benefit of prevention, a new secondary analysis of the Partners PrEP Study suggests.

continue reading
1/23/2015

Enrolling in Medicaid is easier for residents nationwide as states offer more automated processes required by the ACA.

continue reading

Healthcare Reform

Public opinion on the Patient Protection and Affordable Care Act’s employer mandate sways with what Americans are told about the provision, according to a recent report.

View More

Companies are increasingly penalizing workers who decline to join "wellness" programs, embracing an element of the healthcare law that has raised questions about fairness in the workplace.

View More

On a national scale, insurance premiums for plans available through the Patient Protection and Affordable Care Act’s (ACA) health insurance marketp

View More

Medicare/Medicaid

Enrolling in Medicaid is easier for residents nationwide as states offer more automated processes required by the ACA.

View More

Increasing Medicaid reimbursement for primary care providers improved appointment access by nearly 8%.

View More

Although national guidelines recommend the use of high-intensity statins after hospitalization for coronary heart disease events.

View More

Pharmaceutical News

Prescription painkillers are used widely by U.S. women of childbearing age, a federal report found.

View More

Merck & Co. is set to voluntarily discontinue manufacturing and distributing the hepatitis C therapy boceprevir in the United States by the end of this year.

View More

Triptans and dihydroergotamine are effective for acute migraine in adults, whereas other drugs lack evidence or should not be used for various reasons.

View More

FDA Activity

The FDA approved Teva Pharmaceutical Industries Ltd's generic version of AstraZeneca Plc's Nexium to treat acid reflux.

View More

The FDA approved NPS Pharmaceuticals Inc's drug Natpara to control hypocalcemia in patients with hypoparathyroidism.

View More

The FDA approved Rockwell Medical Inc's drug Triferic for treating iron loss in chronic kidney disease patients on dialysis.

View More

Healthcare News

For 19 diseases where mortality is a common outcome, screening of asymptomatic adults does not result in reductions in all-cause mortality.

View More

US demand for healthcare services appears low heading into 2015, lending weight to the investment thesis that an improving economy will not lead healthcare spending to skyrocket.

View More

Early colonoscopy and treatment step-up as needed is more effective than standard drug therapy alone for preventing postoperative recurrence of Crohn's disease.

View More

Guideline Updates

The Endocrine Society published updated clinical practice guidelines on the pharmacological management of obesity outlines a plan for the use of weight-loss agents.

View More

During a workshop at the Cardiometabolic Risk Summit the ACC/AHA and NLA guidelines were discussed, including the recommendations for treatment and the differences between the 2.

View More

Existing guidelines for treating epididymitis are still appropriate, even though they are based on studies published years ago.

View More
Implementation of employee-based wellness programs is gaining momentum, particularly due to the passage of the Patient Protection and Affordable Care Act. continue reading
The first accountable care organizations were implemented in 2005, beginning with just 10 large multispecialty groups of approximately 5000 physicians. Since then, the idea has been widely debated and ultimately encouraged under the Patient Protection and Affordable Care Act. continue reading